allo-715: novel allogenic car t-cell therapy in myeloma
Published 3 years ago • 192 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
4:02
allo-715: bcma allogeneic car-t in r/r myeloma
-
3:47
allo-715 and allo-647: novel car-t products in r/r myeloma
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
0:51
novel allo-cart therapies and their role in the treatment of hematological malignancies
-
1:26
an insight into ctx130: a novel allogeneic car-t cell therapy
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
21:38
drawing the line: the rationale behind blood tube collection order
-
6:06
larvol: the future of oncology data intelligence | new frontiers exclusive
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
0:46
future developments in myeloma treatment
-
1:46
personalized treatments to manage post-transplantation outcomes in aml: insights from morpho
-
2:20
novel car-t products in the pipeline for multiple myeloma
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
2:19
novel avenues for mm treatment: car t-cells, venetoclax, induction & mrd
-
0:47
novel targets in car-t therapy for multiple myeloma: integrin beta-7 & cd98 heavy chain
-
1:15
bringing novel agents to the frontline setting in myeloma
-
1:02
the use of car-t cell products in a real-world setting
-
1:10
cell expansion and vector design in novel t-cell therapies
-
1:11
exciting updates in all and the value of novel immunotherapies
-
5:39
naturally selected cd7 car-t therapy without genetic manipulations for t-all/lbl
-
4:34
development and evaluation of a novel car-t cell therapy against calr mutant neoplasms
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms